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Abstract
Objectives. To evaluate how the level of evidence perceived by an international panel of experts was concordant with the level
of evidence found in the literature, to compare experts perceived level of evidence to their appropriateness scores, and to com-
pare appropriateness criteria for colonoscopy between experts and an evidence-based approach.
Design. Comparison of expert panel opinions and systematic literature review regarding the level of evidence and appropriate-
ness of colonoscopy indications.
Participants. European Panel on the Appropriateness of Gastrointestinal Endoscopy multidisciplinary experts from 14 European
countries.
Main outcome measures. Concordance and weighted kappa coefficient between level of evidence as perceived by the experts’
and that found in the literature, and between panel- and literature-based appropriateness categories.
Results. Experts overestimated the level of published evidence of 57 indications. Concordance between the level of evidence
perceived by the experts and the actual level of evidence found in the literature was 36% (weighted kappa 0.18). Indications for
colonoscopy were reported to be appropriate, uncertain, and inappropriate by the experts in 54, 19, and 27% of the cases, and
by the literature in 37, 46, and 17% of the cases. A 46% agreement (weighted kappa 0.29) was found between literature-based
and experts’ appropriateness criteria.
Conclusions. Experts often overestimated the level of evidence on which they based their decisions. However, rarely did the
experts’ judgement completely disagree with the literature, although concordance between panel- and literature-based appro-
priateness was only fair. A more explicit discussion of existing evidence should be undertaken with the experts before they
evaluate appropriateness criteria.
Keywords: colonoscopy, colorectal cancer, concordance, level of evidence, RAND appropriateness method, weighted kappa
Clinical practice guidelines (guidelines) may contribute to
enhance quality of care [1]. A prerequisite is that guidelines
should be systematically developed and based on the best
available evidence [2]. In the absence of high-quality evidence
from published literature, expert opinion is often used [3].
However, expert opinion is considered to be the literature’s
lowest level of evidence [4], and the development process of
recommendations based on expert opinion is not always
explicit, leading thus to scepticism concerning their merit and
usefulness. The non-systematic development of guidelines,
including lack of transparency about how experts’ judgement is
elicited or formulated, has been acknowledged to be respons-
ible for the variations in guidelines quality and content [5–9].
The RAND Appropriateness Method (RAM), developed
during the 1980s, combines expert opinion with a compre-
hensive review of available scientific evidence and is the
most widely accepted method of developing appropriateness
criteria from which recommendations can be derived [10].
One way to validate RAM results is to compare experts’
judgements to literature-based evidence. In a previous study,
we observed that the degree of agreement between recom-
mendations for the use of colonoscopy developed by Swiss
experts and published evidence was moderate to good [11].
In this study, we focused our analysis on the relationship
between the level of evidence found in the literature and the
level of evidence as perceived by the panel of experts. The
objectives of this study were, firstly, to evaluate to what
extent the level of evidence perceived by an international
panel of experts was in agreement with the level of evidence
found in the literature, secondly, to compare the experts’ per-
ceived level of evidence to their appropriateness scores, and
thirdly, to compare appropriateness criteria for colonoscopy
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between experts and an evidence-based approach. We
hypothesized that the concordance between the perceived
level of evidence and the level of evidence actually existing in
the literature would be relatively good, because the RAM is
based on an extensive literature review which should consti-
tute a reference ground for experts’ judgement and panel dis-
cussion. Since appropriateness criteria for performing
colonoscopy were based on existing evidence, we also
hypothesized that the concordance between panel- and litera-
ture-based criteria would be at least moderate to good (i.e.
corresponding to a kappa value of 0.5–0.8).
Methods
This study used the RAM, a formal group process modified
from the Delphi method [10]. Briefly, in the framework of the
European Panel on the Appropriateness of Gastrointestinal
Endoscopy (EPAGE), a list of all the possible clinical indica-
tions for performing both upper and lower gastrointestinal
endoscopy was first developed, based on an extensive litera-
ture review and completed by information obtained from
experts. This list totalled about 600 indications. Then, a panel
of experts studied the literature review, considered the litera-
ture in light of their own clinical experience, discussed, and
rated the appropriateness of a series of indications to perform
a gastrointestinal endoscopy. Further details about the meth-
odology of the EPAGE project can be found elsewhere [12].
In this study, only the subset of 95 colorectal cancer
screening indications was considered. They related to screen-
ing for early diagnosis of colorectal cancer in asymptomatic
patients (n = 37), in patients with inflammatory bowel disease
(n = 29), and after polypectomy or curative-intent resection of
a colorectal cancer (n = 29). In November 1998, a multidisci-
plinary panel of 14 experts (8 gastroenterologists, 2 surgeons,
and 4 primary care physicians) from nine European countries
met in Lausanne, Switzerland, to develop appropriateness cri-
teria for performing colonoscopy. The ratings were confiden-
tial and took place in two rounds. The results of the first
rating, done independently at home and forwarded to the
organizers, were distributed to all experts during the panel
meeting allowing them to compare their own ratings to those
of their fellows. The second rating took place during the
panel meeting, and its results were used to determine the
appropriateness of each indication.
The definition of appropriateness which was used by the
experts was the following: the indication to perform a medical
procedure is appropriate if the expected health benefit
exceeds the possible negative consequences by a sufficiently
wide margin that the medical procedure is worth performing.
Financial costs have no direct bearing on the appropriateness
of the procedure evaluated by this method [10].
Ratings were scored on a 9-point scale (1, extremely inap-
propriate; 5, uncertain; and 9, extremely appropriate), and the
median panel rating was used to summarize the panel’s rat-
ings. For each indication, colonoscopy was rated appropriate
if the median rating was 7–9 without disagreement, and inap-
propriate if the median rating was 1–3 without disagreement.
Otherwise, the appropriateness was considered uncertain.
Disagreement was defined, as occurring in this 14-member
panel, as four panellists rating in the 1–3 range and four pan-
ellists rating in the 7–9 range for the same indication [10].
A total of 226 relevant articles were retrieved from various
computerized databases (Medline, Embase and Cochrane
Library), analysed, and summarized in a review which was
given to the experts as a framework of evidence upon which
to base their judgements [12]. The literature review was
reported in a series of four articles [13–16].
The literature level of evidence was evaluated based on the
study design as proposed by the evidence-based medicine
approach. We used a five-level (I–V) summary table derived
from a published list [17]. The level of existing evidence
according to the expert was measured on a four-category
scale (A–D), which was developed by the experts participat-
ing in the European Commission BIOMED Concerted
Action on the appropriateness of medical and surgical proce-
dures which supported this project. When comparing the lev-
els of evidence, the categories II, III, and IV of the literature’s
hierarchy of evidence were combined under the label of ‘con-
trolled and observational trials’, in order to have four catego-
ries for both measures of level of evidence (Table 1). The
classification of the level of evidence from the literature was
done independently by two persons, and disagreements were
resolved by joint review of the articles.
On the basis of the literature only, appropriateness catego-
ries (appropriate, uncertain, and inappropriate) were also
defined for each of the 95 indications. An indication for colon-
oscopy was considered appropriate if all study results were
concordant and in favour of colonoscopy, inappropriate if all
study results were concordant but not in favour of colonos-
copy, and uncertain otherwise. Colonoscopy indications for
which we did not find evidence from the literature were con-
sidered as uncertain. We did not attribute different weights to
the studies according to their design or quality. Sensitivity ana-
lysis was performed using other classification schemes of liter-
ature-based categories. Firstly, the indication was considered
appropriate if 2/3 (and not all) of the studies gave concordant
results and secondly, the recommendation from the article
showing the highest level of evidence was considered to be the
reference for the appropriateness measure.
Concordance and weighted kappa coefficients between the
level of evidence as perceived by the experts’ and the level of
evidence found in the literature as well as between the panel-
and literature-based appropriateness categories were calcu-
lated. Proportion of concordance corresponds to the ratio of
the number of indications for which both the results of the
panellists and of the literature were identical, divided by the
total number of indications (95). Kappa is a measure of relia-
bility for categorical measures. It is designed to correct for
chance agreement and calculated as follows:
where Po is the observed concordance and Pe the concord-
ance expected by chance alone. Weighted kappa is a variant of
Κ =
−
−
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P
o e
e1
Appraisal of evidence by experts
179
kappa that gives ‘full credit’ when two observations agree
exactly, and ‘partial credit’ when they disagree, depending on
how far apart these two measurement are [18]. Several
weighting schemes exist; we used 1 – |i – j|/(k – 1), where i
and j index the rows and columns of the ratings by the two
raters, and k is the maximum number of possible ratings.
All statistical analyses were done using STATA 7.0.
Results
Concordance between the two persons who classified the
level of evidence from the literature was 96% (weighted
kappa 0.96) when considering the cases of early detection of
colorectal cancer in patients with inflammatory bowel dis-
eases, 49% (weighted kappa 0.41) when considering cases of
early detection of colorectal cancer after polypectomy or cur-
ative-intent resection, and 47% (weighted kappa 0.46) when
considering cases of early detection of colorectal cancer in
asymptomatic patients.
On average, the time experts spent studying the literature
review was 7.9 hours [19]. The concordance between the level
of evidence as perceived by the experts and the actual level of
evidence in the literature was 36% (n = 34), corresponding to
a weighted kappa of 0.18 ( Table 2). Experts overestimated the
level of evidence of 57 indications (60%) and underestimated
it in four indications (4%). Among the studies identified and
included in the literature review, ‘own opinion/experience’
was never cited collectively by the experts, even though no
proof existed for 14 indications. In the presence of reliable
level of evidence, the proportion of indications judged to be
uncertain was lowest (2/26, 8%) (Table 3).
Table 4 summarizes the concordance table, comparing the
level of appropriateness according to the literature and to the
experts for each of the 95 colorectal cancer screening indica-
tions. Compared with the appropriateness criteria derived
from the literature, the panel of experts considered more
colonoscopies to be either appropriate (54 versus 37%) or
inappropriate (27 versus 17%). Uncertainty was noted in 46%
of the indications according to the literature but only in 19%
according to the experts. Thus, full concordance between the
literature’s and experts’ appropriateness criteria was found in
46% of the cases (n = 44, weighted kappa 0.29), and full dis-
cordance occurred in only seven cases (7.4%). Sensitivity ana-
lysis showed that slightly higher weighted kappas were
obtained when broader criteria of literature appropriateness
were used. A weighted kappa of 0.41 was found when 2/3 of
the articles agreed in their recommendations, and a weighted
kappa of 0.31 when the article with the highest level of evi-
dence was considered to be the reference.
Discussion
We examined how much the level of evidence from literature
and experts’ perceived level of evidence were associated. We
also compared the agreement of appropriateness criteria for
colonoscopy between a panel of experts and a literature-based
approach. The finding that experts often overestimated the
level of evidence on which they based their medical decisions
should be emphasized. Even though we rarely noticed com-
plete discordance between experts and literature, the
weighted kappa coefficient indicated only fair agreement.
Why do physicians, even if considered clinical experts by
their peers, overestimate the level of evidence of published lit-
erature on which they base their medical decisions? Actually,
most experts were not experienced methodologists in critical
literature appraisal, and grading the quality of evidence is a
difficult process, which is reflected by the fact that evidence
from four randomized clinical trials was not acknowledged as
reliable evidence by the experts. Despite the existence of sev-
eral systems for grading the level of evidence, none seemed to
incorporate all the important concepts and dimensions
required [4], which prompted a group of experts to develop
the GRADE system [20]. However, despite having addressed
key shortcomings of the above-mentioned tools, the evalua-
tion of the GRADE approach showed many areas of dis-
agreements, underscoring the complexity of judgements
about evidence [21]. We can therefore expect non-experts in the
domain to be less accurate in the assessment of the level of
Table 1 Scales used for the level of evidence from literature and experts’ perceived level of evidence
Literature hierarchy of evidence Experts’ perceived level of evidence Examples of study designs
...................................................................................... .......................................................................................................................................
I Randomized controlled trial or 
systematic review
A Reliable scientific evidence or guideline 
based on that kind of evidence
Randomized controlled trial
II Clinical controlled trial 
(without randomization)
B Weaker scientific evidence Clinical controlled trial 
(without randomization)
III Cohort study B Weaker scientific evidence Observational studies
IV Retrospective study B Weaker scientific evidence Observational studies
V Case report, case series, 
experts’ opinion
C Experts’ opinion Descriptive studies, 
reviews, experts’ opinion
Nihil D Own or peers’ opinion Own opinion, no evidence 
from literature
I. Peytremann Bridevaux et al.
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evidence found in the literature [22]. The apparent difficulties
of panel experts to appraise the level of published evidence
underscores the need for a more explicit appraisal of the mer-
its and limitations of the relevant studies in the literature
review. For instance, a more systematic use of evidence tables
and the GRADE approach may prove useful. In addition,
during the panel meeting, the chair person possibly helped by
methodologists fully aware of the relevant specific literature,
should systematically include an explicit reminder about the
strengths and limitations of existing evidence and a related
discussion with the clinician experts, before they rate appro-
priateness criteria.
Compared with the 1994 panel of Swiss experts who rated
appropriateness criteria for gastrointestinal endoscopy [11],
appropriateness agreement between panel and literature was
lower in our study. This is contrary to our initial hypothesis
and unexplained. In fact, we would have imagined agreement
to be higher when more homogeneous subsets of colonos-
copy indications were considered, or when cases for which
the balance between benefits and risks was easier to make,
therefore leading to easier judgement of appropriateness. Dif-
ferences in the way indications and/or studies were selected
(more restrictive selection of articles in 1994 likely to lead to a
higher concordance) may however be a possible explanation.
Table 2 Concordance table that compares the experts’ perceived level of evidence with the level of evidence from the
literature, for each of the 95 indications (n)
RCT, randomized controlled trial.
1As defined in the Methods section.
Experts’ perceived level 
of evidence1 ...................................................................................................................................................................
Level of evidence from the literature1
RCT Controlled trials, 
observational trials
Descriptive, 
experts’ opinions
No proof Marginal total 
[n (%)]
................................................................................................................ ...............................................................................................................
Reliable level of evidence 4 16 1 5 26 (27)
Weaker level of evidence 4 21 26 4 55 (58)
Experts’ opinion 0 0 9 5 14 (15)
Own or peers’ 
experience/opinion
0 0 0 0 0 (0)
Marginal total [n (%)] 8 (8) 37 (39) 36 (38) 14 (15) 95 (100)
Table 3 Relation between the experts’ level of appropriateness and perceived level of evidence (n)
Experts’ appropriateness 
categories ....................................................................................................................................................................
Experts’ perceived level of evidence
Reliable level 
of evidence
Weaker level 
of evidence
Experts’ 
opinion
Own or peers’ 
experience/opinion
Marginal total 
[n (%)]
............................................................................................................................................................................................................................
Appropriate 20 26 5 0 51 (54)
Uncertain 2 12 4 0 18 (19)
Inappropriate 4 17 5 0 26 (27)
Marginal total [n (%)] 26 (27) 55 (58) 14 (15) 0 (0) 95 (100)
Table 4 Concordance table comparing the level of appropriateness according to the literature and to the expert panel, for each
of the 95 indications (n)
According to the panel of experts
................................................................................................................................................
According to the literature
Appropriate Uncertain Inappropriate Marginal total [n (%)]
........................................................... ............................................................................................................. ...................................................
Appropriate 27 21 3 51 (54)
Uncertain 4 9 5 18 (19)
Inappropriate 4 14 8 26 (27)
Marginal total [n (%)] 35 (37) 44 (46) 16 (17) 95 (100)
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Lack of attention to the current literature, time lag between
the publication of results and their knowledge, use in clinical
practice, and lack of familiarity with the skills needed for the
evaluation of evidence are some of the cited speculative rea-
sons for lack of agreement between experts’ and literature
appropriateness [11]. In specific clinical situations, disagree-
ment also appears when there is uncertainty regarding risks
and benefits of a procedure. These reasons, among others, are
considered to be weaknesses of RAM [23,24]. We also do not
know which benefits and risks panellists were considering in
their evaluations, and whether these were similar to those
examined in the literature. In addition, other factors, such as
clinicians’ or patients’ values and prior beliefs about treatment
effectiveness, affect clinical decision making and may help
explain why physicians may disagree on patients’ management
despite possible agreement on the evidence [25]. Our seven
indications of full discordance between literature- and panel-
based appropriateness categories were found to correspond,
in an international multicentre observational study of the
appropriateness of use of colonoscopy to 32 of 6004 colono-
scopies (0.6%) [26]. A unique indication was encountered 28
times: high risk of colorectal cancer (non-polypomatous
hereditary colorectal cancer) in an individual aged 20 years or
more, with no previous colonoscopy. There were, however,
no clear patterns that could explain the disagreements. In a
few instances, literature-based evidence was relatively new
and in opposition with a more usual practice reflected by
experts’ opinion.
The use of a multidisciplinary and international panel of
experts, less prone to biases than single discipline or single
country panels [18,27,28], the use of a validated method
(RAM) and the conduct of sensitivity analysis were important
strengths of this study. However, our study does have limita-
tions. Firstly, the interpretation of concordance or of a kappa
coefficient is impaired when the scales compared are not
defined in the same way, or when the categories considered
are not similar. Indeed, the categories of appropriateness and
of levels of evidence we used for both the panel- and the liter-
ature-based approaches were not quite comparable. There-
fore, the results can only be considered as indicative. In
addition, categories were relatively broad and the uncertain
category included indications for which no evidence was
found in the literature. Secondly, the design only, and not the
quality of the study, was considered. Misclassification of the
level of evidence in the literature can therefore not be
excluded. In addition, the modest agreement between the two
persons who classified the level of evidence of the articles
retrieved from the literature review indicates the actual diffi-
culties in attributing a level of evidence to a specific study
design and may thus contribute to understand the lack of con-
cordance between the level of evidence from the literature
and the level of evidence as perceived by the experts. Thirdly,
the literature review was done in 1998, and several articles
have been published since then. However, our objective was
to emphasize the methodological issue of agreement and the
exploration of concordance between two contemporaneous
measures of level of evidence, rather than to specifically look
at colonoscopy indications. Therefore, we would not expect
major differences in our findings had the panel been orga-
nized more recently. Lastly, the limited number of experts
(14) and indications (95) urges to cautious interpretation of
some comparisons, because they were carried out on small
numbers.
In conclusion, experts often overestimated the level of
evidence available in the literature. In addition, only rarely did
the experts’ judgement completely disagree with the literature,
although concordance between panel- and literature-based
appropriateness was only fair. This underscores the need for
panel-based methods of developing appropriateness criteria
to include more explicit discussion about the strengths and
limitations of existing evidence, with the clinician experts,
before they rate appropriateness criteria.
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